JOHN LEE: Open Payments
NPI 1598441792 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 12 payments from 5 companies in 2025. Trend: 2023 $157 · 2024 $576 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $211 |
| Axsome Therapeutics, Inc. | 2 | $127 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: INGREZZA, Auvelity, REXULTI, SPRAVATO, Qelbree.
Industry payments across NY — which companies pay providers there.
